Reducing antibiotic prophylaxis: impact on endocarditis incidence.

Antibiotic prophylaxis before dental procedures has been the gold standard in preventing infective endocarditis, despite the lack of supporting evidence. In 2008, the National Institute for Health and Clinical Excellence in the UK recommended the cessation of antibiotic prophylaxis before dental procedures and other invasive procedures. 

Prescription rates were drastically reduced after 2008 recommendation and, as a consequence, infective endocarditis rates increased significantly both in high and moderate risk groups.

Conclusion

Since the new guidelines on prophylaxis cessation were adopted in 2008, a significant increase in infective endocarditis was observed. Further studies are needed to reconsider the strategies currently in place. 


Mark J Dayer
2014-11-19

Original Title: The Incidence of Infective Endocarditis in England is Increasing – An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics.

More articles by this author

Mitral valve repair in moderate ischemic mitral regurgitation

Article Up to 50% of acute myocardial infarctions are associated to mitral regurgitation of some degree and 10% of these cases present, at least, moderate...

INHERIT: Losartan in hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is the most common hereditary cardiac pathology (1/1500) and is associated to heart failure, angina, arrhythmia, and sudden death.  So far, no...

Atenolol vs. Losartan in children and young adults with Marfan syndrome

Article Aortic root dissection is the main cause of mortality in Marfan syndrome. Recent studies suggest that losartan could more effective to slow aortic root...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...